UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients

Journal of thrombosis and haemostasis, 2012-07, Vol.10 (7), p.1363-1370

2012

Volltextzugriff (PDF)

Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles

Journal of thrombosis and haemostasis, 2010-02, Vol.8 (2), p.315-323

2010

Volltextzugriff (PDF)

Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?

Journal of thrombosis and haemostasis, 2007-03, Vol.5 (3), p.520-527

2007

Volltextzugriff (PDF)

Functional analysis of two haplotypes of the human endothelial protein C receptor gene

Arteriosclerosis, thrombosis, and vascular biology, 2014-03, Vol.34 (3), p.684

2014

Volltextzugriff (PDF)

Genome‐wide linkage scan in affected sibling pairs identifies novel susceptibility region for venous thromboembolism: Genetics In Familial Thrombosis study

Journal of thrombosis and haemostasis, 2013-08, Vol.11 (8), p.1474-1484

2013

Volltextzugriff (PDF)

Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism

Thrombosis research, 2010-10, Vol.126 (4), p.345-349

2010

Volltextzugriff (PDF)

von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis

Journal of thrombosis and haemostasis, 2006-12, Vol.4 (12), p.2556-2562

2006

Volltextzugriff (PDF)

Determinants of the APTT‐ and ETP‐based APC sensitivity tests

Journal of thrombosis and haemostasis, 2005-07, Vol.3 (7), p.1488-1494

2005

Volltextzugriff (PDF)

Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues

Journal of thrombosis and haemostasis, 2004-02, Vol.2 (2), p.257-265

2004

Volltextzugriff (PDF)

Matrix Metalloproteinase-9 Gene −1562C/T Polymorphism Mitigates Preeclampsia

Placenta (Eastbourne), 2007-07, Vol.28 (7), p.709-713

2007

Volltextzugriff (PDF)

Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect

The Lancet (British edition), 1993-01, Vol.341 (8838), p.134-138

1993

Volltextzugriff (PDF)

A new functional assay of thrombin activatable fibrinolysis inhibitor

Journal of thrombosis and haemostasis, 2005-06, Vol.3 (6), p.1284-1292

2005

Volltextzugriff (PDF)

Ischemic stroke in young patients with activated protein C resistance : a report of three cases belonging to three different kindreds

Stroke (1970), 1995-05, Vol.26 (5), p.885-890

1995

Volltextzugriff (PDF)

Microparticle‐associated tissue factor activity in cancer patients with and without thrombosis

Journal of thrombosis and haemostasis, 2009-08, Vol.7 (8), p.1421-1423

2009

Volltextzugriff (PDF)

Functional characterization of transcription factor binding sites for HNF1‐alpha, HNF3‐beta (FOXA2), HNF4‐alpha, Sp1 and Sp3 in the human prothrombin gene enhancer

Journal of thrombosis and haemostasis, 2003-08, Vol.1 (8), p.1688-1698

2003

Volltextzugriff (PDF)

Venous Thrombosis — The Interaction of Genes and Environment

The New England journal of medicine, 1998-06, Vol.338 (25), p.1840-1841

1998

Volltextzugriff (PDF)

Inhibition of thrombin‐mediated factor V activation contributes to the anticoagulant activity of fibrinogen γ

Journal of thrombosis and haemostasis, 2013-09, Vol.11 (9), p.1669-1678

2013

Volltextzugriff (PDF)

Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor

Journal of thrombosis and haemostasis, 2008-02, Vol.6 (2), p.346-351

2008

Volltextzugriff (PDF)

Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis

Journal of thrombosis and haemostasis, 2004-08, Vol.2 (8), p.1305-1310

2004

Volltextzugriff (PDF)

ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden

Journal of thrombosis and haemostasis, 2005-01, Vol.3 (1), p.183-185

2005

Volltextzugriff (PDF)

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

The Lancet (British edition), 1994-11, Vol.344 (8935), p.1453-1457

1994

Volltextzugriff (PDF)

Microparticles expressing tissue factor are concurrently released with markers of inflammation and coagulation during human endotoxemia

Journal of thrombosis and haemostasis, 2012-06, Vol.10 (6), p.1185-1188

2012

Volltextzugriff (PDF)

Cysteine‐mutations in von Willebrand factor associated with increased clearance

Journal of thrombosis and haemostasis, 2005-10, Vol.3 (10), p.2228-2237

2005

Volltextzugriff (PDF)

G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3′‐end formation

Journal of thrombosis and haemostasis, 2004-01, Vol.2 (1), p.119-127

2004

Volltextzugriff (PDF)

Plasma fibrinogen γ′ chain content in the thrombotic microangiopathy syndrome

Journal of thrombosis and haemostasis, 2007-01, Vol.5 (1), p.62-69

2007

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(62)

Sprache

Englisch
(62)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Thrombosis And Haemostasis
(32)
Thrombosis Research
(8)
Blood
(5)
The Lancet
(4)
Clinica Chimica Acta
(3)
Arteriosclerosis, Thrombosis, And Vascular Biology
(2)
Biochemistry
(2)
J Thromb Haemost
(2)
Gastroenterology
(1)
Haemostasis
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients

Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles

Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?

Functional analysis of two haplotypes of the human endothelial protein C receptor gene

Genome‐wide linkage scan in affected sibling pairs identifies novel susceptibility region for venous thromboembolism: Genetics In Familial Thrombosis study

Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism

von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis

Determinants of the APTT‐ and ETP‐based APC sensitivity tests

Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues

Matrix Metalloproteinase-9 Gene −1562C/T Polymorphism Mitigates Preeclampsia

Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect

A new functional assay of thrombin activatable fibrinolysis inhibitor

Ischemic stroke in young patients with activated protein C resistance : a report of three cases belonging to three different kindreds

Microparticle‐associated tissue factor activity in cancer patients with and without thrombosis

Functional characterization of transcription factor binding sites for HNF1‐alpha, HNF3‐beta (FOXA2), HNF4‐alpha, Sp1 and Sp3 in the human prothrombin gene enhancer

Venous Thrombosis — The Interaction of Genes and Environment

Inhibition of thrombin‐mediated factor V activation contributes to the anticoagulant activity of fibrinogen γ

Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor

Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis

ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

Microparticles expressing tissue factor are concurrently released with markers of inflammation and coagulation during human endotoxemia

Cysteine‐mutations in von Willebrand factor associated with increased clearance

G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3′‐end formation

Plasma fibrinogen γ′ chain content in the thrombotic microangiopathy syndrome

Aktive Filter

Suchergebnisse filtern